{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:07:19Z","timestamp":1789207639021,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T00:00:00Z","timestamp":1187308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kinetoplastid Biol Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1475-9292-6-7","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T18:11:44Z","timestamp":1187374304000},"source":"Crossref","is-referenced-by-count":38,"title":["Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis"],"prefix":"10.1186","volume":"6","author":[{"given":"Hashim","family":"Ghalib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Modabber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,17]]},"reference":[{"issue":"6","key":"46_CR1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","volume":"51","author":"EE Zijlstra","year":"1994","unstructured":"Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW: Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. American Journal of Tropical Medicine and Hygiene. 1994, 51 (6): 826-836.","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"46_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","volume":"3","author":"EE Zijlstra","year":"2003","unstructured":"Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM: Post kala-azar dermal leishmaniasis. Lancet Infectious Disease. 2003, 3: 87-98. 10.1016\/S1473-3099(03)00517-6.","journal-title":"Lancet Infectious Disease"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1179\/000349802125002211","volume":"96","author":"AM Musa","year":"2002","unstructured":"Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, Mukhtar MM, El Hassan AM: The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Annals of Tropical Medicine and Parasitology. 2002, 96: 65-72. 10.1179\/000349802125002211.","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"46_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1365-3156.2001.00776.x","volume":"6","author":"AM El-Hassan","year":"2001","unstructured":"El-Hassan AM, Khalil EA: Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?. Tropical Medicine & International Health. 2001, 6: 743-744. 10.1046\/j.1365-3156.2001.00776.x.","journal-title":"Tropical Medicine & International Health"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1172\/JCI116570","volume":"92","author":"HW Ghalib","year":"1993","unstructured":"Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, Russo DM, Reed SG: Interleukin 10 production correlates with pathology in human Leishmania donovani infections. Journal of Clinical Investigation. 1993, 92: 324-329.","journal-title":"Journal of Clinical Investigation"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH: Drug resistance in leishmaniasis. Clinical Microbiology Reviews. 2006, 19: 111-126. 10.1128\/CMR.19.1.111-126.2006.","journal-title":"Clinical Microbiology Reviews"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1086\/500138","volume":"42","author":"S Sundar","year":"2006","unstructured":"Sundar S, Mehta H, Chhabra A, Singh V, Chauhan V, Desjeux P, Rai M: Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis. Clinical Infectious Diseases. 2006, 42: 608-613. 10.1086\/500138.","journal-title":"Clinical Infectious Diseases"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1179\/136485905X514127","volume":"99","author":"AM Musa","year":"2005","unstructured":"Musa AM, Khalil EA, Mahgoub FA, Hamad S, Elkadaru AM, El Hassan AM: Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Ann Trop Med Parasitol. 2005, 99: 563-569. 10.1179\/136485905X514127.","journal-title":"Ann Trop Med Parasitol"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0035-9203(03)90093-9","volume":"97","author":"J Convit","year":"2003","unstructured":"Convit J, Ulrich M, Zerpa O, Borges R, Aranzazu N, Valera M, Villarroel H, Zapata Z, Tomedes I: Immunotherapy of American cutaneous leishmaniasis in Venezuela, 1990 to 1999. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2003, 97: 469-472. 10.1016\/S0035-9203(03)90093-9.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","volume":"99","author":"J Convit","year":"2004","unstructured":"Convit J, Ulrich M, Polegre MA: Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and BCG \u2013 preliminary report. Mem\u00f3rias do Instituto Oswaldo Cruz. 2004, 99: 57-62. 10.1590\/S0074-02762004000100010.","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"5","key":"46_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0738-081X(96)00040-5","volume":"14","author":"O Genaro","year":"1996","unstructured":"Genaro O, de Toledo VP, da Costa CA, Hermeto MV, Afonso LC, Mayrink W: Vaccine for prophylaxis and immunotherapy, Brazil. Clinical Dermatology. 1996, 14 (5): 503-12. 10.1016\/0738-081X(96)00040-5.","journal-title":"Clinical Dermatology"},{"key":"46_CR12","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","volume":"23","author":"A Khamesipour","year":"2005","unstructured":"Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S, Modabber F: Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005, 23: 3642-3648. 10.1016\/j.vaccine.2005.02.015.","journal-title":"Vaccine"},{"key":"46_CR13","first-page":"903","volume-title":"New generation vaccines","author":"F Modabber","year":"2004","unstructured":"Modabber F, Campos-Netto A, Reed S: Vaccines against leishmaniasis. New generation vaccines. Edited by: Levine M, Kaper JB, Rino Rappuoli R, Liu MA, Good MF. 2004, New York, Dekker, 903-914."},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","volume":"99","author":"ID Velez","year":"2005","unstructured":"Velez ID, Gilchrist K, Arbelaez MP, Rojas CA, Puerta JA, Antunes CM, Zicker F, Modabber F: Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005, 99: 593-598. 10.1016\/j.trstmh.2005.04.002.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","volume":"19","author":"A Misra","year":"2001","unstructured":"Misra A, Dube A, Srivastava B, Sharma P, Srivastava JK, Katiyar JC, Naik S: Successful Vaccination against Leishmania donovani infection in Indian Langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine. 2001, 19: 3485-3492. 10.1016\/S0264-410X(01)00058-5.","journal-title":"Vaccine"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","volume":"163","author":"RT Kenney","year":"1999","unstructured":"Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K: Protective immunity using recombinant human 1L-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol. 1999, 163: 4481-4488.","journal-title":"J Immunol"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","volume":"351","author":"I Sharifi","year":"1998","unstructured":"Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MRA, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F: Randomized vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 1998, 351: 1540-1544. 10.1016\/S0140-6736(98)09552-X.","journal-title":"Lancet"},{"key":"46_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","volume":"17","author":"AZ Momeni","year":"1998","unstructured":"Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F: A randomised, double blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 1998, 17: 466-472. 10.1016\/S0264-410X(98)00220-5.","journal-title":"Vaccine"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"EAG Khalil","year":"2000","unstructured":"Khalil EAG, El Hassan , Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil A, Elsheikh M, Modabber F: Autoclaved L. major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 2000, 356: 1565-1569. 10.1016\/S0140-6736(00)03128-7.","journal-title":"Lancet"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0035-9203(03)90171-4","volume":"97","author":"AA Kamil","year":"2003","unstructured":"Kamil AA, Khalil EAG, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, Elhassan AM: Alum-precipitated autoclaved L. major plus BCG, a candidate vaccine for visceral leishmaniasis: safety, skin delayed hypersensitivity response and dose finding in healthy volunteers. Trans Roy Soc Trop Med & Hyg Trans R Soc Trop Med Hyg. 2003, 97: 365-368. 10.1016\/S0035-9203(03)90171-4.","journal-title":"Trans Roy Soc Trop Med & Hyg Trans R Soc Trop Med Hyg"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2249.2005.02768.x","volume":"140","author":"EAG Khalil","year":"2005","unstructured":"Khalil EAG, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM: Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clinical and experimental immunology. 2005, 140: 349-353. 10.1111\/j.1365-2249.2005.02768.x.","journal-title":"Clinical and experimental immunology"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","volume":"41","author":"J Machado-Pinto","year":"2002","unstructured":"Machado-Pinto J, Pinto J, da Costa CA, Genaro O, Marques MJ, Modabber F, Mayrink W: Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. Int J Dermatol. 2002, 41: 73-78. 10.1046\/j.1365-4362.2002.01336.x.","journal-title":"Int J Dermatol"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","volume":"70","author":"RN Coler","year":"2002","unstructured":"Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG: Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis. Infect Immun. 2002, 70: 4215-4225. 10.1128\/IAI.70.8.4215-4225.2002.","journal-title":"Infect Immun"},{"issue":"11","key":"46_CR24","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","volume":"157","author":"JR Webb","year":"1996","unstructured":"Webb JR, Kaufmann D, Campos-Neto A, Reed SG: Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. Journal of Immunology. 1996, 157 (11): 5034-5041.","journal-title":"Journal of Immunology"},{"key":"46_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0166-6851(97)00115-1","volume":"89","author":"JR Webb","year":"1997","unstructured":"Webb JR, Campos-Neto A, Skieky YA, Reed SG: Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major. Molecular and Biochemical Parasitology. 1997, 89: 179-193. 10.1016\/S0166-6851(97)00115-1.","journal-title":"Molecular and Biochemical Parasitology"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","volume":"66","author":"JR Webb","year":"1998","unstructured":"Webb JR, Campos-Neto A, Ovendale PJ, Martin TI, Stromberg EJ, Badaro R, Reed SG: Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infection and Immunity. 1998, 66: 3279-3289.","journal-title":"Infection and Immunity"},{"key":"46_CR27","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","volume":"69","author":"A Campos-Netto","year":"1998","unstructured":"Campos-Netto A, Porrozzi R, Greeson K, Coler RN, Webb JR, Seiky YA, Reed SG, Grimaldi G: Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infection and Immunity. 1998, 69: 4103-4108. 10.1128\/IAI.69.6.4103-4108.2001.","journal-title":"Infection and Immunity"},{"key":"46_CR28","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","volume":"70","author":"A Campos-Netto","year":"2002","unstructured":"Campos-Netto A, Webb JR, Greeson K, Coler RN, Skeiky YA, Reed SG: Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB\/c mice. Infection and Immunity. 2002, 70: 2828-2836. 10.1128\/IAI.70.6.2828-2836.2002.","journal-title":"Infection and Immunity"},{"key":"46_CR29","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1002\/eji.1830271024","volume":"27","author":"P Probst","year":"1997","unstructured":"Probst P, Skeiky YA, Steeves M, Gervassi A, Grabstein KH, Reed SG: A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. European Journal of Immunology. 1997, 27: 2634-2642. 10.1002\/eji.1830271024.","journal-title":"European Journal of Immunology"},{"key":"46_CR30","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1084\/jem.181.4.1527","volume":"181","author":"YA Skeiky","year":"1995","unstructured":"Skeiky YA, Guderian JA, Benson DR, Bacelar O, Carvalho EM, Kubin M, Badaro R, Trinchieri G, Reed SG: A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. The Journal of Experimental Medicine. 1995, 181: 1527-1537. 10.1084\/jem.181.4.1527.","journal-title":"The Journal of Experimental Medicine"},{"issue":"11","key":"46_CR31","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","volume":"161","author":"YA Skeiky","year":"1998","unstructured":"Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG: LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. Journal of Immunology. 1998, 161 (11): 6171-6179.","journal-title":"Journal of Immunology"},{"key":"46_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","volume":"21","author":"RN Coler","year":"2005","unstructured":"Coler RN, Reed SG: Second-generation vaccines against leishmaniasis. Trends in Parasitology. 2005, 21: 244-249. 10.1016\/j.pt.2005.03.006.","journal-title":"Trends in Parasitology"},{"key":"46_CR33","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0966-842X(02)02426-5","volume":"10","author":"DH Persing","year":"2002","unstructured":"Persing DH, Coler RN, Lacy MJ, Johnson DA, Baldridge JR, Hershberg RM, Reed SG: Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends in Microbiology. 2002, 10: S32-S37. 10.1016\/S0966-842X(02)02426-5.","journal-title":"Trends in Microbiology"},{"key":"46_CR34","first-page":"223","volume":"5","author":"R Badaro","year":"2001","unstructured":"Badaro R, Lobo I, Nakatani M, Muinos A, Netto EM, Coler RN, Reed SG: Successful use of a defined antigen\/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report. The Brazilian journal of infectious diseases. 2001, 5: 223-232.","journal-title":"The Brazilian journal of infectious diseases"},{"key":"46_CR35","doi-asserted-by":"crossref","unstructured":"Badaro R, Lobo I, Munos A, Netto EM, Modabber F, Campos-Neto A, Coler RN, Reed SG: Immunotherapy for drug-refractory mucosal leishmaniasis. J Infect Dis. 194 (8): 1151-9. 10.1086\/507708. 2006 Oct 15","DOI":"10.1086\/507708"}],"container-title":["Kinetoplastid Biology and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-9292-6-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-9292-6-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-9292-6-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T20:44:33Z","timestamp":1684010673000},"score":1,"resource":{"primary":{"URL":"https:\/\/kinetoplastids.biomedcentral.com\/articles\/10.1186\/1475-9292-6-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/1475-9292-6-7","relation":{},"ISSN":["1475-9292"],"issn-type":[{"value":"1475-9292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,17]]},"article-number":"7"}}